Carl B Camras
UNMC Department of Ophthalmology · University of Nebraska
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Carl B Camras as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:17 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00579969 · Comparison of Latanoprost Vs. TimololUniversity of Nebraska · terminated · Glaucoma · principal investigator
- Ph2NCT00572936 · Circadian Rhythms of Aqueous Humor Dynamics in HumansUniversity of Nebraska · completed · Glaucoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- PG-INDUCED REDUCTION OF INTRAOCULAR PRESSURER01EY007865 · NEI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · fiscal years 1989 to 1993 · $140,623 awarded in 1993Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:17 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- 462 citationsRCR 24.3
- Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.Ophthalmology · 1993367 citationsRCR 19.8
- Effects of brimonidine on aqueous humor dynamics in human eyes.Arch Ophthalmol · 1995257 citationsRCR 11.9
- Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.Ophthalmology · 1996212 citationsRCR 10.5
- Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.Am J Ophthalmol · 1999132 citationsRCR 5.4
- Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.Ophthalmology · 1989103 citationsRCR 5.8
- Effects of apraclonidine on aqueous humor dynamics in human eyes.Ophthalmology · 199593 citationsRCR 4.5
- Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension.Arch Ophthalmol · 199266 citationsRCR 3.9
- Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group.Am J Ophthalmol · 199862 citationsRCR 2.8
- Inhibition of the epinephrine-induced reduction of intraocular pressure by systemic indomethacin in humans.Am J Ophthalmol · 198551 citationsRCR 3.9